E M Pharma Ilkeston - Ilkeston

E M Pharma Ilkeston: A Comprehensive Overview

For individuals and organizations seeking a reliable pharmaceutical supplier, E M Pharma Ilkeston presents itself as a noteworthy entity. Located in the heart of the UK, specifically at Unit 4, Lydal Court, Manners Industrial Estate, Unit 4 Lyndale Court, Birkdale Cl, Ilkeston DE7 8EF, this company specializes in the production and distribution of pharmaceutical products. It’s important to note that as of the current data available, E M Pharma Ilkeston has 0 reviews on Google My Business, suggesting a relatively new or less publicly visible operation. However, this doesn't diminish the importance of understanding their capabilities and operational details.

Contact Information and Website

To facilitate communication and further investigation, the company’s contact details are readily available. The primary telephone number is 1664820347. Potential clients and partners can also access the company’s website at empharma.co.uk. This website likely provides detailed information regarding their product offerings, manufacturing processes, and quality control standards.

Location and Accessibility

The physical location of E M Pharma Ilkeston is strategically situated within the Manners Industrial Estate in Ilkeston, Derbyshire. This industrial setting suggests a focus on efficient logistical operations and potentially close proximity to transport networks. Furthermore, the company offers a wheelchair-accessible car park, demonstrating a commitment to inclusivity and ease of access for all visitors. This is a key consideration for businesses and individuals requiring convenient access to the facility.

Specialties and Core Business

E M Pharma Ilkeston’s core business revolves around being a dedicated pharmaceutical company. While specific product details may require direct inquiry through their website or telephone, it’s reasonable to assume they engage in the formulation, manufacturing, and possibly packaging of various pharmaceutical ingredients or finished products. The company likely adheres to stringent regulatory guidelines and quality control protocols mandated by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). The nature of their operations suggests a focus on supplying materials or products to other pharmaceutical manufacturers, distributors, or potentially healthcare providers.

Operational Details and Considerations

Given the limited publicly available information, a deeper assessment necessitates contacting E M Pharma Ilkeston directly. Key areas of inquiry should include:

• Product Portfolio: A comprehensive list of the pharmaceutical products manufactured or supplied by the company.
• Regulatory Compliance: Confirmation of adherence to MHRA regulations and GMP (Good Manufacturing Practice) standards.
• Quality Control: Details regarding their quality assurance processes and validation procedures.
• Supply Chain: Understanding their sourcing of raw materials and distribution channels.
• Manufacturing Capabilities: Insights into the scale and complexity of their manufacturing operations.

Average Opinion and Future Potential

Currently, E M Pharma Ilkeston’s average opinion stands at 0/5 on Google My Business. This lack of reviews underscores the company's relatively nascent presence online. However, a low number of reviews does not automatically reflect a negative assessment. It could simply indicate a recent establishment or a limited online marketing strategy. As the company grows and establishes a stronger online presence, it’s expected that customer feedback and reviews will accumulate, providing a more comprehensive understanding of their service quality and operational performance.

Key Features Summary

Here’s a concise summary of E M Pharma Ilkeston’s key features:

Recommendations for Prospective Clients

For individuals or organizations seeking to engage with E M Pharma Ilkeston, a proactive approach is recommended. Direct contact via telephone or through their website is crucial to gather detailed information about their capabilities and suitability for specific needs. Due to the limited online presence, a thorough assessment of their regulatory compliance and quality control processes is highly advisable. Furthermore, exploring potential partnerships or supply agreements should be undertaken following a comprehensive evaluation of their offerings.